Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
Huntington's Disease Association · National Hospital for Neurology and Neurosurgery · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
314
total citations
- FWCI
- 31.19
- Percentile
- 100%
- References
- 125
Citations per year
Authors
10- SJSarah J. TabriziCorresponding
Huntington's Disease Association, National Hospital for Neurology and Neurosurgery, University College London
- CECarlos Estevez‐Fraga
National Hospital for Neurology and Neurosurgery, Huntington's Disease Association, University College London
- WVWilleke van Roon‐Mom
Leiden University Medical Center
- MFMichael Flower
National Hospital for Neurology and Neurosurgery, Huntington's Disease Association, University College London
- RIRachael I. Scahill
National Hospital for Neurology and Neurosurgery, Huntington's Disease Association, University College London
Topics & keywords
Topics
Keywords
- Huntingtin
- Huntington's disease
- Disease
- Huntingtin Protein
- Trinucleotide repeat expansion
- Biology
- RNA splicing
- Bioinformatics
No related works found for this paper.
Funding
- RRoche
- CFCHDI Foundation
- TPTeva Pharmaceutical Industries
- WTWellcome TrustAward: 200181/Z/15/Z
- HAHealth and Care Research Wales
- EHEuropean Huntington's Disease Network
- ASAlzheimer's Society
- RTRosetrees Trust
- CUCardiff University
- ARAlzheimer’s Research UK
- UDUK Dementia Research Institute
- CICanadian Institutes of Health Research
- MRMedical Research CouncilAwards: MR/T033428/1, MR/L010305/1
- H2Horizon 2020